We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

90 hedge funds and large institutions have $148M invested in CTI BioPharma Corp. (DE) Common Stock in 2014 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

548% more call options, than puts

Call options by funds: $2.61M | Put options by funds: $402K

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

47% more capital invested

Capital invested by funds: $100M → $148M (+$47M)

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

6% more funds holding

Funds holding: 85 → 90 (+5)

Holders
90
Holders Change
+5
Holders Change %
+5.88%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
22
Increased
32
Reduced
13
Closed
16
Calls
$2.61M
Puts
$402K
Net Calls
+$2.2M
Net Calls Change
+$441K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$11.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.16M
3
RCM
RA Capital Management
Massachusetts
+$5.78M
4
DCM
DAFNA Capital Management
California
+$3.29M
5
TC
TFS Capital
Pennsylvania
+$3M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$978K
2
Jane Street
Jane Street
New York
-$901K
3
Deutsche Bank
Deutsche Bank
Germany
-$703K
4
HCM
Highbridge Capital Management
New York
-$311K
5
EEG
E.E. Geduld
-$97K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eagle Asset Management
Florida
$30M +$11.2M +485,954 +62%
State Street
2
State Street
Massachusetts
$14.1M +$1.14M +49,130 +9%
BIT
3
BlackRock Institutional Trust
California
$12M +$437K +18,909 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$10.8M +$983K +42,533 +10%
BFA
5
BlackRock Fund Advisors
California
$9.83M +$2.11M +91,123 +28%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$9.35M +$9.16M +396,000 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$8.01M – – –
RCM
8
RA Capital Management
Massachusetts
$5.9M +$5.78M +250,000 New
Northern Trust
9
Northern Trust
Illinois
$3.79M +$191K +8,244 +5%
DCM
10
DAFNA Capital Management
California
$3.36M +$3.29M +142,500 New
TC
11
TFS Capital
Pennsylvania
$3.06M +$3M +129,574 New
ACP
12
Acuta Capital Partners
California
$2.9M +$2.84M +122,811 New
CS
13
Candriam SCA
Luxembourg
$2.65M +$2.6M +112,500 New
Jane Street
14
Jane Street
New York
$2.47M -$901K -38,962 -27%
TA
15
Teachers Advisors
New York
$1.96M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.93M +$39.8K +1,723 +2%
Citadel Advisors
17
Citadel Advisors
Florida
$1.77M +$1.69M +73,219 +3,804%
SFM
18
Sphera Funds Management
Israel
$1.77M +$1.73M +75,000 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$1.73M +$36.2K +1,565 +2%
Renaissance Technologies
20
Renaissance Technologies
New York
$1.39M -$978K -42,295 -42%
Goldman Sachs
21
Goldman Sachs
New York
$1.39M +$311K +13,461 +30%
SCM
22
Sio Capital Management
New York
$1.19M +$1.17M +50,500 New
LOAMU
23
Lombard Odier Asset Management (USA)
New York
$1.18M +$1.16M +50,144 New
TCIM
24
TIAA CREF Investment Management
New York
$1.12M -$33.4K -1,446 -3%
Millennium Management
25
Millennium Management
New York
$1.11M +$1.06M +45,791 +3,367%
1
2 3 4 5

CTIC Hedge Fund Activity: Q4 2014 in Review

90 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q4 2014, worth a combined $148M — up 47% from $100M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CTIC positions and 16 closed out — a net gain of 6 holders — while 32 added to existing stakes and 13 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $11.2M. The largest seller was Renaissance Technologies, cutting an estimated $978K.

  • 90 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q4 2014, up from 85 in Q3 2014.
  • Funds reported $148M of CTI BioPharma Corp. (DE) Common Stock stock for Q4 2014, up 47% quarter-over-quarter.
  • 22 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q4 2014 and 16 closed out, a net change of +6 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q4 2014 was Eagle Asset Management, an estimated $11.2M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q4 2014 was Renaissance Technologies, an estimated $978K sold.

Based on aggregated 13F filings for Q4 2014.